Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jul;35(4):763-773.
doi: 10.1111/ipd.13288. Epub 2024 Dec 6.

A Prospective Randomised Clinical Trial Evaluating Pulpotomy in Primary Molars With Three Bioceramic Calcium Silicate Cements: 24 Month Follow-Up

Abhinav L Talekar  1   2 , Prasad K Musale  3   4 , Gayatri S Chaudhari  1   2 , Tayaba M H Silotry  5 , William F Waggoner  6
Affiliations
Randomized Controlled Trial

A Prospective Randomised Clinical Trial Evaluating Pulpotomy in Primary Molars With Three Bioceramic Calcium Silicate Cements: 24 Month Follow-Up

Abhinav L Talekar et al. Int J Paediatr Dent. 2025 Jul.

Abstract

Background: In recent times, bioceramic calcium silicates have gained attention due to high success rates with pulpotomy in primary teeth.

Aims: To evaluate and compare the clinical and radiographic outcomes of three different bioceramic calcium silicate cements in vital deciduous teeth treated with pulpotomies over a period of 24 months.

Design: Children aged 4-9 years, with deep dentinal caries (ICDAS 4-6) in primary molars, having no history of spontaneous pain or signs of non-vitality were included in the study. Following clinical and radiographic evaluation 117 primary molars diagnosed as having reversible pulpitis received pulpotomy treatment, after randomly being assigned into three groups based on the bioceramic calcium silicate medicament used: a pre-mixed syringe-loaded MTA putty (NeoPUTTY); a traditional powder-liquid hand mix MTA material (NeoMTA Plus), and a precapsulated, trituration mixed material (Biodentine). Clinical and radiographic evaluation was done at 6, 12, 18 and 24 months.

Results: The cumulative clinical and radiographic success for NeoPUTTY was 92%, NeoMTA Plus 97% and for Biodentine 95% and 89%, respectively, after 24 months follow-up.

Conclusion: The clinical and radiographic success rates of all three bioceramic calcium silicate cements were found to be high, with no significant differences over a period of 24 months.

Trial registration: Clinical trial registration number: CTRI/2021/03/031655.

PubMed Disclaimer

References

    1. I. Parisay, J. Ghoddusi, and M. Forghani, “A Review on Vital Pulp Therapy in Primary Teeth,” Iranian Endodontic Journal 10, no. 1 (2015): 6–15.
    1. A. Igna, “Vital Pulp Therapy in Primary Dentition: Pulpotomy‐A 100‐Year Challenge,” Children 8, no. 10 (2021): 841, https://doi.org/10.3390/children8100841.
    1. N. S. Seale and J. A. Coll, “Vital Pulp Therapy for the Primary Dentition,” General Dentistry 58, no. 3 (2010): 194–202.
    1. J. A. Coll, N. S. Seale, K. Vargas, A. A. Marghalani, S. Al Shamali, and L. Graham, “Primary Tooth Vital Pulp Therapy: A Systematic Review and Meta‐Analysis,” Pediatric Dentistry 39, no. 1 (2017): 16–123.
    1. N. A. Aminabadi, R. M. Farahani, and S. G. Oskouei, “Formocresol Versus Calcium Hydroxide Direct Pulp Capping of Human Primary Molars: Two Year Follow‐Up,” Journal of Clinical Pediatric Dentistry 34, no. 4 (2010): 317–321, https://doi.org/10.17796/jcpd.34.4.pntq604021604234.

Publication types

MeSH terms

LinkOut - more resources